Differential effects of transdermal nicotine on microstructured analyses of ties in Tourette's syndrome: An open study

Psychological Medicine

Volumn 27, Issue 2, 1997, Pages 483-487

  Dursun, Serdar M ^a,b   Reveley, Michael A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NICOTINE; NICOTINIC RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; TIC; TIME; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VIDEORECORDING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NICOTINE; RECEPTORS, NICOTINIC; TOURETTE SYNDROME; TREATMENT FAILURE;

EID: 0030965482     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291796003984     Document Type: Article

References (17)

1. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised (DSM-III-R). APA: Washington, DC.
2. Balfour, D. J. K. (1989). Influence of nicotine on the release of monoamines in the brain. Progress in Brain Research 79, 165-172.
3. Dursun, S. M. & Handley, S. L. (1991). Tic-like movements induced by TRH-amide: differential effects of ritanserin and haloperidol. British Journal of Pharmacology 102, 229P.
4. 1A receptor agonists in the mouse. British Journal of Pharmacology 109, 1046-1052.
5. Dursun, S. M. & Handley, S. L. (1994). Complex of rapid movements and vocalization induced by RX336-M in mice: possible relevance to Tourette's syndrome. Journal of Psychopharmacology 8, 27-31.
6. Dursun, S. M., Reveley, M. A., Bird, R. & Stirton, R. F. (1994). Long lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 344, 1577.
7. Dursun, S. M., Bird, R. & Reveley, M. A. (1995a). Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome. British Journal of Clinical Pharmacology 39, 100P-101P.
8. Dursun, S. M., Burke, J. G. & Reveley, M. A. (1995b). Buspirone treatment of Tourette's syndrome. Lancet 345, 1366-1367.
9. Goetz, C. G., Tanner, C. M., Wilson, R. S. & Shannon, K. M. (1987). A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data. Neurology 37, 1542-1544.
10. Handley, S. L. & Dursun, S. M. (1992). Serotonin and Tourette's syndrome: movements such as head-shakes and wet-dog shakes may model human tics. Advances in the Biosciences 85, 235-253.
11. Karson, C. N. (1988). Physiology of normal and abnormal blinking. Advances in Neurology 49, 25-37.
12. Klein, R. G., Abikoff, H., Barkley, R. A., Campbell, M., Leckman, J. F., Ryan, N. D., Solanto, M. V. & Whalen, C. K. (1994). Clinical trials in children and adolescents. In Clinical Evaluation of Psychotropic Drugs (ed. R. F. Prien and D. S. Robinson), pp. 501-546. Raven Press: New York.
13. Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J. & Cohen, D. (1989). The Yale Global Tic Severity Scale. Journal of the American Academy of Child and Adolescent Psychiatry 28, 566-573.
14. 2-dopamine receptor density. Biochemistry and Biophysics Research Communications 159, 48-52.
15. Reveley, M. A., Bird, R., Stirton, R. F. & Dursun, S. M. (1994). Microstructural analysis of the symptoms of Tourette's syndrome and the effects of a trial use of transdermal nicotine patch. Journal of Psychopharmacology Supplement 117, A30.
16. Robertson, M. M. (1989). The Gilles de la Tourelle syndrome: the current status. British Journal of Psychiatry 154, 147-169.
17. Silver, A. A. & Sanberg, P. R. (1993). Transdermal nicoline patch and potentiation of haloperidol in Tourette's syndrome. Lancet i, 182.